Zoetis Inc (ZTS)
Zoetis is a holding company. Through its subsidiaries, Co. develops, manufactures and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests and animal health technology. Co.'s product categories include: vaccines, which are biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; and parasiticides, which are products that prevent or eliminate parasites. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision animal health.
Zoetis SEC Filing Email Alerts Service
| Company Name: |
Zoetis Inc |
| Stock buyback: |
ZTS buyback |
| Website: |
www.zoetis.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding ZTS: |
106 |
| Total Market Value Held by ETFs: |
$8.77B |
| Total Market Capitalization: |
$70.06B |
| % of Market Cap. Held by ETFs: |
12.52% |
|
|
April 19, 2024 • 2:57 AM Eastern
Strong Buy (3.96 out of 4)
100th percentile
|
|
Free ZTS Email Alerts:
